Skip to main content
. Author manuscript; available in PMC: 2019 Feb 11.
Published in final edited form as: J Comp Neurol. 2017 Jul 24;525(16):3488–3513. doi: 10.1002/cne.24283

Table 1:

Tracer injections in the supratemporal plane (and STG)

Case Area injected Tracer Vol. (μL) Conc. Supplier & Catalog # Fig. #
1 (OR-r) AI (caudal) FR 0.5 5% Molecular Probes
D-1817/D-3308
1A; 3
2 (VA-r) AI (rostral) DY 0.5 3% Sigma D-0281 1B; 4
3 (OR-l) AI/R FE 0.5 5% Mol. Probes D-1820 1C
4 (VA-r) R (caudal) FE 0.5 5% Mol. Probes D-1820 1D; 5
5 (OR-r) R (mid) FE 0.5 5% Mol. Probes D-1820 1E; 5
6 (VA-l) R (rostral) DY 0.5 3% Sigma D-0281 1F
7 (VA-r) RT (caudal) FB 0.5 3% Sigma F5756 1G; 4
8 (VA-l) RT (rostral) FR 0.5 5% Molecular Probes
D-1817/D-3308
1H; 7
9 (CC-r) RT (rostral) DY 0.5 3% Sigma D-0281 1I; 6
10 (OR-l) RT/RTp DY 0.3 3% Sigma D-0281 1J; 8
11 (SP-r) RTp BDA 1.0 10% Mol. Probes D1956 1K; 11
12 (CC-l) RTp DY 0.5 3% Sigma D-0281 1L
13 (MQ-r) RTp (STGr) CTB 1.0 2% List Biological 103B 1M; 9
14 (OR-l) RTp BDA 0.5 10% Mol. Probes D1956 1O; 11
15 (VA-r) RTp FR 0.5 5% Molecular Probes
D-1817/D-3308
1P; 10
16 (CC-l) STGr/TGdg CTB 0.5 2% List Biological 103B 1N; 12